-
Stay Connected
Get the latest news on exciting speakers, workshops & learning opportunities at ISDE 2021.
Subscribe for Updates
Advanced oesophageal cancer can make eating and drinking distressing. A focus on Palliative Care in Advanced Esophageal Cancer: Improving Quality of Life means placing comfort, dignity and the patient’s choices alongside disease-directed treatment, with support adjusted as needs change.
Palliative care should start when symptoms become hard to manage, not only in the final days. Earlier involvement allows time to clarify goals, co-ordinate medication and practical assistance, prepare family caregivers and respond to problems before they become crises.
ISDE 2021, the virtual 17th World Congress for Esophageal Diseases, brought clinicians and researchers together through scientific sessions, workshops and abstracts. Organised by the International Society for Diseases of the Esophagus, the programme shows how evidence, practical training and international collaboration can advance care for complex symptoms such as progressive dysphagia.
Patients may navigate surgery, chemoradiotherapy, immunotherapy, stenting and palliative treatment in varying combinations. Care should remain accessible, culturally safe and coordinated across hospital, community and home settings, particularly when treatment preferences and illness trajectories are uncertain.
The first clinical conversation should ask what the person wants life to feel like, not merely which procedures are available. Explore priorities such as eating favourite foods, remaining at home, seeing family or managing pain independently, and record realistic options in language the patient understands.
Advance care planning should follow, with discussion of resuscitation, hospital transfer and preferred place of care. Australian state and territory laws recognise advance care directives, but witnessing and validity requirements differ. Use the form valid where the patient lives and appoint a substitute decision-maker where appropriate.
A structured symptom review should cover pain, reflux, nausea, dry mouth, cough, breathlessness, fatigue, bleeding and changes in swallowing. Medicines can be tailored for neuropathic pain, gastric protection, nausea and breathlessness, including carefully titrated opioids for severe pain. Radiotherapy, stenting and other procedures should be considered when they match the person’s goals and likely benefit.
Not every swallowing problem is tumour progression. Infection, benign stricture and other disorders can coexist, so reassessment matters when symptoms change or treatment response is poor. The ISDE 2021 report on oesophageal tuberculosis and dysphagia shows why rare but important causes must not be dismissed, while invasive testing remains proportionate to the person’s condition and wishes.
A dietitian can translate dysphagia into safe, tolerable choices: modified textures, small frequent meals, energy-dense options and oral nutritional supplements when appropriate. Fluid plans and posture advice should address dehydration and aspiration risk, with repeated review as the tumour and appetite change.
Food also carries social meaning. In Australia, coffee breaks, shared meals, weekend barbecues and takeaway after work may matter more than nutritional totals alone. A local dietitian, community pharmacy or home-care supplier can help families locate suitable foods and equipment, but treatment should follow the patient’s preferences rather than a rigid menu.
Distress can include anticipatory grief, depression, anxiety, shame about eating and fear of losing independence. Brief screening, counselling, peer support and practical respite give patients and caregivers room to express these concerns without feeling that food refusal means giving up.
Care should be culturally safe, with Aboriginal and Torres Strait Islander health teams involved where patients choose and professional interpreters used when language is a barrier. Ask who the patient considers family, how much information they want to share, and what rituals or foods have importance at this stage.
Access is shaped by Australia’s mixed funding system. Medicare rebates support GP and specialist consultations, many medicines are subsidised through the Pharmaceutical Benefits Scheme, and public palliative-care services are funded through state and territory health systems. Private health insurance may assist with some allied services, but it does not create a complete palliative-care pathway.
Major centres such as Melbourne and Sydney usually offer broader hospital, community and hospice services. In rural and remote areas, limited workforce coverage and long travel distances can make continuity harder. Telehealth, local nursing, pharmacy support and a clearly named coordinator can reduce isolation. Access should be reviewed rather than assumed from a referral alone.
Palliative care depends on a team with defined roles: oncology, specialist palliative care, nursing, dietetics, pharmacy, allied health, social work and primary care. Regular case reviews and a single agreed treatment plan help avoid conflicting advice, duplicated medicines and gaps between inpatient and community care.
Workforce education should cover structured symptom assessment, opioid safety, communication, cultural safety and escalation planning. ISDE 2021 workshops and congress abstracts offer useful continuing development, while local protocols should convert those learning points into referrals, documentation standards and after-hours contacts that staff can apply.
Support at home may involve a symptom diary, medicines organised for easy access, a comfortable eating position, small equipment and a written contact plan for the care team. Carers need clear instructions about what can wait, what needs same-day advice and what constitutes an emergency, along with realistic permission to rest between tasks.
The immediate next step is a scheduled 30-minute goals-of-care review, after which the signed plan is entered in the clinical notes and a copy is placed in the patient’s home care folder.